1. Home
  2. RRC vs LEGN Comparison

RRC vs LEGN Comparison

Compare RRC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$38.77

Market Cap

9.8B

Sector

Energy

ML Signal

HOLD

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.45

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
LEGN
Founded
1976
2014
Country
United States
United States
Employees
N/A
3200
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
3.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RRC
LEGN
Price
$38.77
$18.45
Analyst Decision
Hold
Strong Buy
Analyst Count
18
12
Target Price
$43.67
$61.33
AVG Volume (30 Days)
2.1M
1.6M
Earning Date
04-21-2026
05-12-2026
Dividend Yield
0.92%
N/A
EPS Growth
151.38
N/A
EPS
2.27
N/A
Revenue
$3,115,515,000.00
N/A
Revenue This Year
$15.60
$42.68
Revenue Next Year
$9.73
$30.52
P/E Ratio
$16.88
N/A
Revenue Growth
28.90
N/A
52 Week Low
$32.68
$16.24
52 Week High
$48.31
$37.50

Technical Indicators

Market Signals
Indicator
RRC
LEGN
Relative Strength Index (RSI) 40.28 42.38
Support Level $38.45 $17.81
Resistance Level $40.70 $19.36
Average True Range (ATR) 1.05 0.77
MACD -0.47 -0.01
Stochastic Oscillator 24.53 34.49

Price Performance

Historical Comparison
RRC
LEGN

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: